Conclusions: Once daily Elbasvir 50mg / Grazoprevir 100mg for 12 weeks is a safe and effective option treatment for patients with HCV genotype 1 infection and chronic kidney disease indicating renal transplantation, needs to be carried out a survey of a larger cohort.